Navigating Market Access With Magnolia: Executing Your Access Strategy When Resources Are Limited

Executing Your Access Strategy When Resources Are Limited
Thursday, August 28, 2025 | 12:00 PM ET

Planning and executing a market access strategy in today’s biopharma market is more complex than ever. Limitations on budget, time, data and evidence, and skilled staffing require more than a standard playbook — they demand smart, coordinated strategies that keep access goals at the forefront.

Join Christine Molbury, Herman Chen, Amanda O’Hora, and Amanda Forys for a practical discussion on how to make every decision, dollar, and data point count. Drawing on expertise in market access, policy, analytics, and evidence generation, they’ll share how to:

• Prioritize access initiatives based on the specific needs of the market
• Coordinate evidence, policy, and reimbursement workstreams for greater impact
• Integrate market insights early to guide brand strategy
• Anticipate and plan for access barriers before they affect launch or growth

Whether you’re a biotech startup or a well-established pharmaceutical manufacturer, don’t miss the opportunity to walk away with strategies you can apply in your next planning cycle. Register now.